CHINO HILLS, CA / ACCESS Newswire / April 10, 2025 / SOHM, Inc. (OTC PINK:SHMN), a pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, is thrilled to announc ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

Kye Pharmaceuticals, Inc. ("Kye") announced today it has submitted a New Drug Submission (NDS) to Health Canada for the regulatory review and approval of AGAMREE® (vamorolone). If approved, AGAMREE® ...

The Nursing Beat, in partnership with B. Braun Medical Inc., a leading medical technology company, today announced the results of a survey of over 500 nurses in the United States indicating a ...

Discover why insurance coverage matters for precision medicine and what solutions can improve equitable, personalized ...

New UCLA research conducted using mouse models and human genetic data has uncovered a critical factor that determines how ...

Researchers have identified type 5 collagen as a key factor in kidney fibrosis, revealing its potential as a biomarker to predict chronic kidney disease progression. A repurposed anti-cancer drug, ...

Eric Cannon, PharmD, FAMCP, discusses how precision medicine advancements and biomarker development can enable targeted ...

Dr. Dan Landau, senior author, the Bibliowicz Family Professor of Medicine, and member of the Englander Institute for Precision Medicine ... use of the redundant information in natural two ...

For more information, visit . Renovaro aims to accelerate precision and personalized medicine for longevity powered by mutually reinforcing AI and biotechnology platforms for early diagnosis ...

LOS ANGELES, April 09, 2025 (GLOBE NEWSWIRE) -- Renovaro Biosciences Inc. (NASDAQ: RENB), a TechBio leader focused on next-generation diagnostics, drug discovery, and genetically enhanced cancer ...